{"id":"W4249126278","doi":"10.1016/j.brachy.2015.02.200","title":"Low-Dose-Rate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavourable Risk Prostate Cancer: The Results of the ASCENDE-RT* Randomized Control Trial","year":2015,"lang":"en","type":"article","venue":"Brachytherapy","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Interior Health; Island Health","funders":"","keywords":"Medicine; Prostate cancer; Brachytherapy; Androgen deprivation therapy; Urology; Clinical endpoint; Randomization; Randomized controlled trial; Prostate; Surgery; Nuclear medicine; Cancer; Internal medicine; Radiation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003780998,0.0005440461,0.001639724,0.0001053255,0.0002720238,0.0000966544,0.0003722922,0.0001893541,0.00005714459],"category_scores_gemma":[0.0009513287,0.0002740841,0.000820788,0.0005747054,0.0003082821,0.0001454127,0.00003589336,0.0003510701,0.00001407797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003301894,"about_ca_system_score_gemma":0.0009470375,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001703161,"about_ca_topic_score_gemma":0.0002555143,"domain_scores_codex":[0.9955783,0.001003834,0.001337462,0.0007296876,0.0006250026,0.0007256816],"domain_scores_gemma":[0.9953481,0.001633257,0.0008137629,0.001146939,0.0006884076,0.000369532],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9409957,0.0008035877,0.002181153,0.00004986287,0.001566946,0.000007922906,0.004815881,0.0004176465,0.001394617,0.00006150636,0.01639484,0.03131036],"study_design_scores_gemma":[0.9086931,0.003736352,0.004767234,0.0002921779,0.0006676819,0.000009580332,0.0001954015,0.001092986,0.02478274,0.00062684,0.05479446,0.0003414637],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9245734,0.005386807,0.0001129507,0.04618587,0.001551221,0.02045658,0.001443254,0.0001437769,0.0001460871],"genre_scores_gemma":[0.9773487,0.006459028,0.000191524,0.007405234,0.0006479667,0.006028609,0.00005141351,0.0001556854,0.001711816],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05277527,"threshold_uncertainty_score":0.9999712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0231220848198861,"score_gpt":0.3059732543734943,"score_spread":0.2828511695536082,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}